AzTrials
AzTrials

Emergency MedicineNLP-DeValNCT06240572

Development of a Natural Language Processing Tool to Enable Clinical Research in Emergency Medicine

An observational study of Emergency Medicine, run by Mario Negri Institute for Pharmacological Research at 8 sites in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this retrospective cohort study is to develop and validate a language model that can interpret the contents of emergency department electronic medical records and extract relevant information for research purposes in all adult patients who arrived at the participating emergency departments in a three-year… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Emergency Medicine
How many people
300,000 participants
Where
8 sitesItaly
Study dates
1 Oct 2024to Sep 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All adult patients who arrived at participating emergency departments between January 1, 2021 and December 31, 2023

Who may be able to join

  • Adult
  • Arrived at emergency department between 1 January 2021 and 31 December 2023

Who cannot join

  • None

Trial locations and contacts

8 sites in 1 country. Contact the study team or a site near you to ask about taking part.

8 sites in 1 country

Italy8 sites, 8 recruiting
  • AOU Policlinico 'G.Rodolico - San Marco'

    Catania

    Giuseppe Carpinteri, +39 095 378 1111, gicarpinteri@gmail.com

    Not yet recruiting
  • Istituto di Ricerche Farmacologiche Mario Negri IRCCS

    Milan, Milan, 20156

    Guido Bertolini, MD, guido.bertolini@marionegri.it

    Not yet recruiting
  • ASST Grande Ospedale Metropolitano Niguarda

    Milan

    Nicolò Capsoni, +39 02 64441, nicolo.capsoni@gmail.com

    Not yet recruiting
  • Ospedale Luigi Sacco

    Milan

    Anna Maria Brambilla, +39 02 39041, brambilla.annamaria@asst-fbf-sacco.it

    Not yet recruiting
  • Ospedale San Luigi Gonzaga

    Orbassano

    Valeria Caramello, +39 011 90261 ext. v.caramello@sa

    Not yet recruiting
  • Ospedale Santa Maria delle Grazie

    Pozzuoli

    Giovanni Porta, +39 081 855 2320, dottorgiovanniporta@gmail.com

    Not yet recruiting
  • Ospedale San Giovanni Bosco

    Torino

    Franco Aprà, +39 011 240 2210, franco.apra@aslcittaditorino.it

    Recruiting
  • Ospedale Sant'Andrea

    Vercelli

    Sergio Tartaglia, +39 0161 593111, srtartaglia@gmail.com

    Recruiting

Other trials in Italy

About this study

Official title: Development and Validation of a Natural Language Processing Tool to Enable Clinical Research in Emergency and Acute Care Medicine: Retrospective Cohort Study

The goal of this retrospective cohort study is to develop and validate a language model that can interpret the contents of emergency department electronic medical records and extract relevant information for research purposes in all adult patients who arrived at the participating emergency departments in a three-year period.

The main question it aims to answer is: is the language model able to interpret the contents of emergency department electronic medical records and extract the requested information from them so that it can be used to make accurate analyses and predictions?

The study is retrospective and data will be extracted automatically from the medical health records.

Read the detailed description

BACKGROUND AND RATIONALE FOR THE STUDY

Conducting clinical and quality-of-care assessment research in emergency medicine is as difficult as it is important. It is difficult because the vast number of patients that need to be treated and the chronic shortage of staff make ad hoc data collection impractical. It is important because, in the end, research enables emergency physicians and nurses to base their practice on evidence obtained in their own, unique setting, as opposed to evidence obtained in far-removed contexts, as is commonly the case today.

The only way to bridge the gap between research needs and availability of robust data is to extract data directly from the electronic health records (EHRs) of emergency departments, avoiding dedicated, time-consuming data collection. This is a difficult task, however, because the most useful information is in free text format (e.g., presence of signs and symptoms, suspected and confirmed diagnosis, anamnesis). Such circumstances and needs require a reliable natural language processing (NLP) tool to derive highly consistent data from free text.

Today, large-scale language models are available that can accurately interpret natural language. These models are trained on huge amounts of general knowledge taken mostly from the Internet, however, so their performance in more specialized areas, such as the medical domain, may not be optimal.

The present study is part of a larger project called eCREAM (enabling Clinical Research in Emergency and Acute-care Medicine), and aims to develop and validate a language model (called eCREAM_LM) for six languages that can interpret the contents of emergency department EHRs and extract relevant information for research purposes.

METHODS

The study is an observational, multicenter, retrospective, 24-month study. Thirty centers will participate in the study: 13 from Italy, 4 from Poland, 3 from Greece, Slovakia, Slovenia, and the United Kingdom, and 1 from Switzerland. The centers will not receive any compensation, but their expenses will be covered by project funds.

Development and validation of the eCREAM_LM model.

eCREAM_LM will be developed through training and fine-tuning of the best overall model, among those open-source, and will proceed in partially parallel phases. Candidate models will be exposed to a huge amount (billions) of medical texts from the scientific literature or other public sources. Simultaneously, the models will also be exposed to a massive amount (millions) of free text notes obtained from medical records in use at participating hospitals. The investigators will then move on to fine-tuning, where a large amount (thousands) of clinical notes, obtained, once again, from the medical records of participating centers, will be used. These notes will be annotated by experienced physicians, which consists of extracting information from the notes to fill in the data items listed in a virtual data collection form (vCRF). The vCRF was created for a related study and contains a set of variables useful in predicting the hospitalization of patients with dyspnea or transient loss of consciousness, which is the objective of the related study. In the current study, the vCRF will serve as a tool for validating the language model.

Validation of eCREAM_LM will be carried out using a set of 1,000 clinical notes annotated as described above, but not used in the development phase. These notes will be submitted to the eCREAM_LM model with the task of compiling the vCRF. The concordance in filling in the vCRF between the expert physicians and the eCREAM_LM will be the measure of final validation of eCREAM_LM.

Data collection and anonymization

Each participating hospital will provide free text notes contained in the medical records of 150-300,000 adult patients treated between 2021 and 2023. Notes referring to different aspects of the same patient (e.g., history, objective examination, test results) will be separated from each other so that it will be impossible to reconstruct the complete profile of the patient. In addition, the notes will be stripped of any reference to the patient (e.g., first name, last name, date of birth) and context (e.g., hospital, date and time of arrival at the center). This process minimizes the likelihood of re-identifying patients and maximizes the protection of their rights. The likelihood of re-identifying a patient within a database depends on how unique his or her characteristics are from other individuals in the database. The likelihood of having unique, and therefore identifiable, patients increases with the amount of information available in the database and decreases with its size. By removing all personal and contextual information from clinical notes and separating each note from the others, each note will only report a few characteristics of the patient. In addition, data collected from hospitals in the same country will be merged so that there is one large database for each language. This effectively zeroes out the probability of there being individuals uniquely identifiable from the notes.

Finally, to rule out the possibility that the notes will contain information about third parties, such as names and phone numbers of patients' relatives, a certified anonymization software, specifically designed to remove personal data from free text, will be installed in each hospital.

Once anonymized, the data will be centralized for analysis and will also be uploaded to major European language resource sharing platforms in the scientific community.

Statistical analysis

In the eCREAM_LM validation, the investigators will assess the concordance between expert emergency physicians and the eCREAM_LM itself in filling in the vCRF. The data will refer to a sample of 1,000 notes for each study language. Concordance will be assessed for each variable of the vCRF using Cohen's κ as a measure of agreement. The eCREAM_LM will be considered valid if Cohen's κ is greater than 0.75.

Sample size

Assuming an excellent agreement (κ=0.80) between eCREAM_LM and the experienced emergency physicians in completing the vCRF, a sample of at least 735 notes will be necessary to achieve sufficient precision to guarantee a good agreement (lower confidence limit of 95% confidence interval of Cohen's κ greater than 0.75). This number is the maximum sample size obtained under different scenarios involving a different number of categories (2 to 5) for each variable and different marginal distributions of the categories in the sample, including balanced distributions (e.g., 5 categories with 20% of the sample in each category) and very imbalanced results (e.g., 5 categories with 1.8%, 7.3%, 16.4%, 29.1% and 45.5% of the sample). Since information of interest may be missing in some notes, the investigators will perform the data validation assessment on 1,000 notes.

Being tested
no intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no interventionOther

    no intervention

Study groups in NCT06240572
Study groupRoleWhat they receive
Adults who attended the emergency departmentNot described
Receives: Other: no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Concordance in filling in the virtual case report form

    Level of concordance in filling in the virtual case report form between the expert physicians and the eCREAM_LM language model

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2024
  2. Study start1 Oct 2024
  3. Primary completionJan 2027 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
300,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06240572
Sponsor's protocol ID
8780
Acronym
NLP-DeVal
Status last verified
Jul 2026
First submitted
26 Jan 2024
Last updated
15 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The anonymized, individual participant data will be uploaded to the major European language resource sharing platforms in the scientific community, including the European Language Grid repository (https://live.europeanlanguage-grid.eu), the CLARIN Virtual Language Observatory (https://vlo.clarin.eu/?2), and the European Language Equality (ELE) initiative (https://european-language-equality.eu).

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Medicine, run by Mario Negri Institute for Pharmacological Research at 8 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Chiara Pandolfini (0039 02 39014 253, chiara.pandolfini@marionegri.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Concordance in filling in the virtual case report form (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in